CN100401925C - 可有效预防和治疗哮喘的健康饮料的制造方法 - Google Patents
可有效预防和治疗哮喘的健康饮料的制造方法 Download PDFInfo
- Publication number
- CN100401925C CN100401925C CNB2005101320313A CN200510132031A CN100401925C CN 100401925 C CN100401925 C CN 100401925C CN B2005101320313 A CNB2005101320313 A CN B2005101320313A CN 200510132031 A CN200510132031 A CN 200510132031A CN 100401925 C CN100401925 C CN 100401925C
- Authority
- CN
- China
- Prior art keywords
- sangmuer
- mixture
- extract
- fermentation
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000006673 asthma Diseases 0.000 title claims abstract description 30
- 235000013361 beverage Nutrition 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 239000000463 material Substances 0.000 claims abstract description 39
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 9
- 241000219357 Cactaceae Species 0.000 claims abstract description 8
- 244000276331 Citrus maxima Species 0.000 claims abstract description 8
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 8
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 8
- 240000003582 Platycodon grandiflorus Species 0.000 claims abstract description 8
- 244000294611 Punica granatum Species 0.000 claims abstract description 8
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 8
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 8
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 8
- 235000008397 ginger Nutrition 0.000 claims abstract description 8
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 7
- 244000175448 Citrus madurensis Species 0.000 claims abstract description 6
- 235000017317 Fortunella Nutrition 0.000 claims abstract description 6
- 244000291564 Allium cepa Species 0.000 claims abstract 2
- 244000088415 Raphanus sativus Species 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 35
- 238000000855 fermentation Methods 0.000 claims description 27
- 230000004151 fermentation Effects 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 230000002269 spontaneous effect Effects 0.000 claims description 11
- 244000302544 Luffa aegyptiaca Species 0.000 claims description 10
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims description 10
- 241000220324 Pyrus Species 0.000 claims description 9
- 244000061458 Solanum melongena Species 0.000 claims description 9
- 235000002597 Solanum melongena Nutrition 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 235000021017 pears Nutrition 0.000 claims description 9
- 244000189799 Asimina triloba Species 0.000 claims description 8
- 235000006264 Asimina triloba Nutrition 0.000 claims description 8
- 235000009467 Carica papaya Nutrition 0.000 claims description 8
- 244000237791 Chionanthus virginicus Species 0.000 claims description 8
- 235000015256 Chionanthus virginicus Nutrition 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 8
- 240000001307 Myosotis scorpioides Species 0.000 claims description 8
- 235000001759 Citrus maxima Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 240000004307 Citrus medica Species 0.000 claims description 6
- 235000011201 Ginkgo Nutrition 0.000 claims description 6
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 239000003978 infusion fluid Substances 0.000 claims description 4
- 238000007598 dipping method Methods 0.000 claims description 2
- 206010011224 Cough Diseases 0.000 abstract description 17
- 238000002156 mixing Methods 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 5
- 244000028550 Auricularia auricula Species 0.000 abstract 2
- 235000000023 Auricularia auricula Nutrition 0.000 abstract 2
- 235000005078 Chaenomeles speciosa Nutrition 0.000 abstract 2
- 240000001980 Cucurbita pepo Species 0.000 abstract 2
- 235000009852 Cucurbita pepo Nutrition 0.000 abstract 2
- 240000000249 Morus alba Species 0.000 abstract 2
- 235000008708 Morus alba Nutrition 0.000 abstract 2
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 abstract 2
- 244000251905 Pseudocydonia sinensis Species 0.000 abstract 2
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 abstract 2
- 235000014443 Pyrus communis Nutrition 0.000 abstract 2
- 240000001987 Pyrus communis Species 0.000 abstract 2
- 244000184734 Pyrus japonica Species 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 2
- 206010036790 Productive cough Diseases 0.000 abstract 1
- 239000010135 fructus aurantii immaturus Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 description 16
- 208000026435 phlegm Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 235000001465 calcium Nutrition 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 241000220259 Raphanus Species 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 206010022000 influenza Diseases 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 241000234282 Allium Species 0.000 description 5
- 230000000857 drug effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 208000005374 Poisoning Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- NLAWPKPYBMEWIR-SKYQDXIQSA-N (2S)-poncirin Chemical compound C1=CC(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 NLAWPKPYBMEWIR-SKYQDXIQSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- NLAWPKPYBMEWIR-VGQRFNKBSA-N Poncirin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C[C@@H](c3ccc(OC)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 NLAWPKPYBMEWIR-VGQRFNKBSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- NAXKFVIRJICPAO-LHNWDKRHSA-N [(1R,3S,4R,6R,7R,9S,10S,12R,13S,15S,16R,18S,19S,21S,22S,24S,25S,27S,28R,30R,31R,33S,34S,36R,37R,39R,40S,42R,44R,46S,48S,50R,52S,54S,56S)-46,48,50,52,54,56-hexakis(hydroxymethyl)-2,8,14,20,26,32,38,43,45,47,49,51,53,55-tetradecaoxa-5,11,17,23,29,35,41-heptathiapentadecacyclo[37.3.2.23,7.29,13.215,19.221,25.227,31.233,37.04,6.010,12.016,18.022,24.028,30.034,36.040,42]hexapentacontan-44-yl]methanol Chemical compound OC[C@H]1O[C@H]2O[C@H]3[C@H](CO)O[C@H](O[C@H]4[C@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]6[C@H](CO)O[C@H](O[C@H]7[C@H](CO)O[C@@H](O[C@H]8[C@H](CO)O[C@@H](O[C@@H]1[C@@H]1S[C@@H]21)[C@@H]1S[C@H]81)[C@H]1S[C@@H]71)[C@H]1S[C@H]61)[C@H]1S[C@@H]51)[C@H]1S[C@@H]41)[C@H]1S[C@H]31 NAXKFVIRJICPAO-LHNWDKRHSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229930007050 cineol Natural products 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- -1 galactan Polymers 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- GUAFOGOEJLSQBT-UHFFFAOYSA-N scoparone Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- GSFDOOHGKOHDEL-UHFFFAOYSA-N Dalpanitin Natural products COc1cc(ccc1O)C2=COc3c(C4OC(CO)C(O)C(O)C4O)c(O)cc(O)c3C2=O GSFDOOHGKOHDEL-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 206010061825 Duodenal neoplasm Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 241000931143 Gleditsia sinensis Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241001632576 Hyacinthus Species 0.000 description 1
- 206010062530 Increased bronchial secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 241001248592 Isaria japonica Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010054184 Small intestine carcinoma Diseases 0.000 description 1
- 206010046607 Urine abnormality Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- XCTGXGVGJYACEI-LCENJUANSA-O delphinidin 3-O-beta-D-glucoside-5-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=[O+]C1=CC(O)=C2)C=3C=C(O)C(O)=C(O)C=3)=CC1=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 XCTGXGVGJYACEI-LCENJUANSA-O 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000000312 duodenum cancer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 235000015206 pear juice Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- SVHDRHWULLNMQC-UHFFFAOYSA-N scoparone Natural products C1=CC(=O)OC2=C1C=C(C(=O)C)C(C(C)=O)=C2 SVHDRHWULLNMQC-UHFFFAOYSA-N 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 150000003464 sulfur compounds Chemical group 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种可有效预防和治疗哮喘的健康饮料的制造方法,即,将切细的丝瓜、梨等主原料和切细的雪花冬虫夏草、木瓜等副原料与红糖均匀混合,并将混合物自然发酵一定时间后过滤,然后在提取物中混合桑木耳粉末,对哮喘,咳嗽,多痰等症有效。本发明包括:混合步骤,将洗净并切细的丝瓜、梨、金橘,萝卜、桔梗等主原料,洗净并切细的雪花冬虫夏草、生姜、木瓜、石榴、银杏、葱头、茄子、枳实、仙人掌、柚子等副原料,红糖以60~70∶20~30∶10~35的重量比混合;发酵步骤,在10-25℃的温度,对混合物进行3~6个月自然发酵;提取步骤,对经发酵的混合物过滤,抽取提取物;桑木耳混合步骤,1kg提取物中混合15~25g的桑木耳粉末。
Description
技术领域
本发明涉及到一种可有效预防和治疗哮喘的健康饮料的制造方法,尤其是,将切细的丝瓜、梨等主原料和切细的雪花冬虫夏草(IsariaJaponica)、木瓜等副原料与红糖均匀混合,并将上述混合物自然发酵一定时间后过滤,然后在提取物中混合粉末状桑木耳而成,对哮喘,咳嗽,多痰等症状有着很好疗效的健康饮料的制造方法。
背景技术
通常,哮喘是由气道的过敏反应引起的突发性呼吸困难,在支气管敏感症中是最痛苦的重病,有时可危及生命。据2000年世界卫生组织(WHO)报告,全世界哮喘患者多大1亿5千万人,而且每年18万人死于哮喘。从儿童到老年人的整个年龄段中,哮喘的发病率在80年代为3~4%,而最近,哮喘发病率则提高到6~7%,尤其是儿童的哮喘发病率高达15%。哮喘症状中,最典型的是伴随哮鸣音的猛烈咳嗽,多痰以及呼吸困难。这种哮喘通过对致敏原的回避,缓和症状的药物治疗,免疫疗法,来预防和缓和其症状,保证患者进行正常的活动。另外,作为民间疗法,开发出很多可有效预防和治疗哮喘的,以动植物为主原料的健康饮料,这种现有健康饮料以动植物为原料,并通过热汤和油脂溶剂提取并饮用,或者长时间泡在酒精或酒中,饮用其提取液。制造时,通过酒精提取,并使用活性炭进行脱色、精制、过滤,同时添加香料,糖分后,将提取液长时间发酵。但是,因各种植物所含的成分不同,所以温度调节很困难,而且植物加热到一定温度后沸腾,无法继续加热,而有些植物进行加热提取时,会产生不必要甚至有害的成分,导致提取液混浊,并形成浮游液或悬浮液,不宜饮用。对这些提取液进行处理,需要经过沉淀,过滤,脱色等程序,生产工序很烦杂。
发明内容
本发明旨在解决上述问题,其目的在于,提供一种可有效预防和治疗哮喘的健康饮料制造方法,即,既不产生加热处理时的不必要成分或有害成分,又不需要复杂的制造工序,可有效预防和治疗哮喘的健康饮料制造方法,包括:将切细的丝瓜、梨、桔梗、萝卜等主原料和切细的雪花冬虫夏草、木瓜等副原料与红糖混合的步骤;将混合物自然发酵一定时间的步骤;从自然发酵的混合物中抽取提取物的步骤;在提取物中添加粉末状桑木耳的步骤。
本发明为了达到上述目的,提供了一种既不产生加热处理时的不必要成分或有害成分,又不需要复杂的制造工序,可有效预防和治疗哮喘、感冒、咳嗽、多痰等症状的健康饮料的简便制造方法,其特征包括:将洗净并切细的丝瓜、梨、金橘,萝卜、桔梗等主原料,以及洗净并切细的雪花冬虫夏草、生姜、木瓜、石榴、银杏、葱头、茄子、枳实、仙人掌、柚子等副原料与红糖进行混合的步骤;对混合物进行一定时间自然发酵的步骤;从自然发酵的混合物中抽取提取物的步骤;在提取物中添加粉末状桑木耳的步骤。
上述桑木耳混合步骤还可分为:在含有20~30%酒精的溶剂92~96wt%中,加入4~8wt%桑木耳,并浸渍10~16个月使桑木耳药性浸出的步骤;将30~40g的上述药性浸出溶液与1kg的上述提取步骤中抽取的提取液进行混合的步骤。
本发明通过将丝瓜、梨、桔梗、金橘、萝卜等主原料和雪花冬虫夏草、木瓜、石榴、银杏、葱头、茄子、枳实、仙人掌、柚子等副原料与红糖进行混合,自然发酵一定时间后抽取提取物,在提取物中添加桑木耳粉末或桑木耳药性浸出的酒精而成。其制造过程很简单,便于制造生产,而且原料的药性成分有助于保持健康,尤其是对哮喘、感冒、咳嗽、多痰等症有很好的疗效,并通过各原料中的抗癌成分,具有一定的抗癌效果。
具体实施方式
以下,对具有上述构成的本发明之可有效预防和治疗哮喘的健康饮料的制造方法,进行详细说明。
在上述混合步骤中,主原料和副原料,以及红糖的重量之比例优选为60~70∶20~30∶10~35。另外,混合时,除了用于哮喘、感冒、咳嗽、多痰等症状的上述主原料和副原料之外,还可适当添加对健康有益的水果、蔬菜、药材等。
上述发酵步骤,优选在10~25℃的温度下,自然发酵3~6个月。而且发酵通过天然酶发生,可克服现有的通过热汤抽取提取液所存在的问题,可提取纯自然的药性成分。
上述桑木耳混合步骤,优选在1kg提取液中添加15~25g桑木耳并进行混合,最优选在含有20~30%酒精的溶剂92~96wt%中,浸渍4~8wt%的桑木耳,并发酵10~16个月,将30~40g的桑木耳药性浸出溶液与1kg的提取液进行混合。这样,通过浸渍在酒精中,可更加有效浸出桑木耳的药性成分。
下面,对本发明中的有效预防和治疗哮喘的健康饮料制造方法,以及在本发明中所用的丝瓜、梨、金橘,萝卜、桔梗等主原料,雪花冬虫夏草、生姜、木瓜、石榴、银杏、葱头、茄子、枳实、仙人掌、柚子等副原料,后添加的桑木耳的特性进行详细说明。
首先,在混合步骤中,将作为主原料的丝瓜、梨、金橘,萝卜、桔梗清洗干净后,切细并混合,然后,同样地将作为副原料的雪花冬虫夏草、生姜、木瓜、石榴、银杏、葱头、茄子、枳实、仙人掌、柚子清洗干净后,切细。
这时,上述主原料的混合物中添加一定比例的副原料和含有少量灰分并具有独特味道和甜味的红糖,其中,上述主原料和副原料以及红糖分别以60~70∶20~30∶10~35的重量比进行配合,可获得本发明所要求的药效。
本发明中所使用的材料特性如下:
主原料之一的丝瓜中含有硝酸钠、不溶性皂角苷、赤霉素、半乳糖、木糖,而丝瓜纤维素中含有木聚糖、甘露聚糖、半乳聚糖、木质素等,具有化痰镇咳之效果,广泛使用于哮喘、结核,积脓症的治疗。
另外,丝瓜性凉,可凉血、促进血液循环,用作利尿剂、还对水肿、头痛等症有效,具有镇痛消炎作用。
梨中,钠、钾、钙、锰的含量占74%,此外磷、乳酸占25%,为强碱性食品。其性凉,可清热通便,还因快速分解体内的酒精成分,故可解酒解渴,梨汁可治咳嗽、哮喘、热病、百日咳、燥渴等症。
而且,梨中丰富的多酚、黄酮类成分具有优异的抗癌、抗炎、抗氧化效果。
橘子中含有柠檬酸,可恢复疲劳,促进新陈代谢,降低血液中的胆固醇值,从而可预防动脉硬化,解除精神压力,预防高血压并稳定血压。
橘子皮中所含柠檬苦素成分可抑制癌细胞的扩散,可治疗流感、肠胃病、浮肿、鱼类中毒等,还含有黄烷酮配糖体中的橙皮苷及柚苷,可强化毛细血管管壁。
萝卜含有丰富的维生素和钙,可助牙齿健康,而且对孕妇也好。其含有淀粉酶、苷、半乳糖酶等消化酶,促进消化,通便。
另外,萝卜汁具有化痰止咳功效,还具有可中和尼古丁的解毒作用,而形成辛味的蒜苷为硫磺化合物,具有抗癌作用。
桔梗含有丰富的糖质、无机质、纤维素,尤其是钙含量很高的碱性食品,含有丰富的铁分,还含有皂角苷,对咳嗽、多痰、呼吸不畅等症状有效,可治感冒引起的咳嗽、多痰、鼻子不通、发冷、头痛等症。
另外,还可治咽喉痛,对扁桃腺炎、咽喉炎有疗效,而且具有优异的排脓作用,故用于肺结核引起的脓痰、咳嗽、咳血等症,可有效治疗哮喘、肺炎、支气管炎、咽喉炎。
其次,副原料中的雪花冬虫夏草,中药中把它与人参、鹿茸列为三大药材,可延缓衰老,并广泛使用于结核、黄疸的治疗药,麻药中毒的解毒剂。
其成分有,水分10.84%、脂肪8.4%、粗蛋白25.32%、碳水化合物28.9%、灰分4.1%,可补肾、润肺、补血,还可化痰止咳,尤其对肺结核、哮喘、腰痛、贫血、肾病等症状有良好的疗效。
另外,含有虫草酸,可提高人体的免疫功能,还具有优异的治愈力,当运动消耗体力时,可缩短疲劳恢复时间,故用于运动员疲劳恢复,强化体力。
另外,冬虫夏草对肺癌、肝癌、***癌等的癌细胞具有85%的抑制效果,并可提高细胞的抵抗力,可有效防治细菌或病毒感染。
其次,生姜中含有龙脑、桉油酚、柠檬醛、苯酚、萜、生物碱、姜醇、姜二醇、姜酮等,可促进消化液分泌,增进食欲,并对痉挛等症状有镇静作用。而且,可提高人体免疫功能,可降低血液中的胆固醇含量,从而可预防高血压、心脏麻痹、脑溢血。
另外,上述桉油酚、萜、苯酚、姜醇等成分具有抗癌效果,广泛使用于抗癌食疗,而且生姜中的姜醇等成分对引起食中毒的菌、沙门氏菌、霍乱菌具有很强的杀菌抗菌作用。另外,具有助扩散的作用,从而在各种处方中添加稍许,可提高药效的扩散,并具有解毒作用。
木瓜中含有水分74~85%、糖质13~20%、纤维质1~4%、灰分0.3~0.7%,含有微量的维生素和矿物质,而糖质中,含有糖分10~13%、有机酸0.8~1.1%,并含有丰富的氨基酸性氮和果胶,可解酒,化痰,故有效于感冒、支气管炎、肺炎、咳嗽等症,还具有促进消化酶的分泌,促消化的功能。
石榴含有丰富的钙、磷、铁、钠、钾等矿物质以及水溶性维生素,烟酸等,可促进葡萄糖的分解,促进新陈代谢,对高血压和动脉硬化等症尤为有效。而且对止血、驱虫、泻痢、痢疾、白带异常等症有疗效。最近发现,石榴中含有大量的***,可有效治疗更年期障碍、骨质疏松症等,还用于糖尿病的改善、强身、美容等领域。
银杏中含有55%的水分以及蛋白质、脂肪、糖质、纤维、灰分、钙等成分,可改善支气管粘液的分泌功能,弛缓支气管的平滑肌,具有化痰、止咳、治哮喘的功效。服用新鲜的银杏可解酒,可治疗尿频、尿液混浊、白带异常、遗精、梦精等症。
葱头中含有大量的钙、盐分、维生素等,用于治疗感冒、去痰、驱虫、利尿,可增强心脏和肠胃的功能,对多种微生物具有抗菌作用。
茄子中含有93%的水分,以及蛋白质、碳水化合物、钙、磷、维生素A、维生素C等成分,在蔬菜中,其营养成分比较低,但形成茄子独特颜色的茄香豆酸花翠素(Nasunin)、风信子花色素(Hyacin)具有吸收脂肪,溶解和排出血管中的废物的功能,从而可清血、降低血液中的胆固醇值。
另外,茄子中含有莨菪亭(Scopoletin)和滨蒿内脂(Scoparone)等可抑制痉挛成分,可起镇静作用并用于镇痛,还可提高肝脏及胰脏功能,另有利尿作用。
枳实中合有柚苷、枸桔苷(Poncirin)等配糖体,胃病及消化不良有效,还用于化痰剂、利尿剂。因具有消炎等解毒作用,对食物中毒或过敏引起的皮疹,搔痒等症有效。
仙人掌中含有三萜、苹果酸、琥珀酸等,具有通气、活血、解毒等功能,用于治疗心脏及胃的疼痛、肿瘤、痢疾、痔疮出血、咳嗽引起的咽喉痛、肺肿、乳肿,生疮、火伤、被蛇咬等部位,尤其是仙人掌鲜汁对胸膜炎有良好疗效,对呼吸道疾病也有效。
柚子所含维生素C含量为柠檬的3倍以上,还包括大量的维生素B复合体以及维生素A母体的胡萝卜素,以及对毛细血管起保护作用的橘皮苷等成分,尤其和别的水果相比,含有大量的钙和纤维素,从而用于预防感冒、恢复疲劳、皮肤美容、增进食欲,以及儿童骨骼形成和预防骨质疏松症。
上述柚子中含有柠檬烯,可促进血液循环,而且对咳嗽、胃癌、肺癌、皮肤癌有抑制作用。因含有橘皮苷,可稳定血压,防止血管老化,预防脑溢血和高血压,而且具有肝脏解毒、恢复疲劳、抗癌、抗过敏,抗炎症、抗菌等作用,从而可改善体质,增强对病的抵抗力。
在发酵步骤,将具有上述药效的主原料、副原料以及红糖的混合物,在自然状态下进行发酵,发酵条件为,在10~25℃的温度范围内进行3~6个月的自然发酵。即,当设定温度在10℃左右时,发酵时间最长6个月,而设定温度为25℃时,发酵时间最长3个月,这样,可避免现有健康饮料中,将各种药用植物或水果经过热汤加热而被提取的有害成分导致提取液不够清澈,形成混浊的浮游液或悬浮液,不宜饮用,且对其处理需要复杂的工序等问题。
如上所述,本发明中的发酵步骤为对天然酶的自然发酵,与现有的热汤提取相比,提取时可避免药效成分的流失,在低温或常温长期发酵中其药效形成,使味和香以及预防和治疗哮喘的药性逐渐成熟。
提取步骤中,对在上述条件中经过自然发酵的混合物进行过滤,抽出提取液,而在桑木耳混合步骤,在上述提取液中添加磨成粉末状的桑木耳,即,相对于1kg的上述提取液,添加15~25g桑木耳粉末并进行混合。
这时,为了更有效地浸出桑木耳的药性,最好在含有20~30%酒精的溶剂92~96wt%中,加入4~8wt%的桑木耳,并浸渍10~16个月,然后,将30~40g的上述桑木耳药性浸出溶液与1kg的上述提取步骤中抽取的提取液进行混合。
在发酵步骤,可将桑木耳粉末或桑木耳药性浸出的酒精添加并一起发酵,以提取药性,但本发明之理想实施例中,将上述酒精药性浸出的酒精添加到提取液中并混合。
这样,可防止桑木耳在发酵时,与别的浮游物一起漂浮,使桑木耳特有的药性无法充分浸出的现象,通过将桑木耳粉末或桑木耳药性浸出的酒精添加到提取液中并进行混合,可充分利用桑木耳的药效。
上述桑木耳与普通菌类不同,其含有蛋白多糖体和多糖体,这些起到免疫活性作用,可提高免疫功能,对病毒、细菌、霉菌、寄生虫、抗癌,抗酸,自由基等方面均有效。
另外,桑木耳用于对各种疾病、大肠菌、肺疾病、摔伤、中毒,过敏、老化、各种病毒感染等的治疗,是现阶段中最有效的免疫强化剂。当消化***中癌症,如胃癌、食道癌、十二指肠癌、结肠癌、直肠癌、以及肝癌等的切割手术后,进行化学疗法时,提高免疫功能,可治疗子宫出血、白带、***、内脏出血、并具有对肠胃功能的活性化以及解毒功能。
通过将上述桑木耳粉末或桑木耳药性浸出的酒精添加到提取液中并进行混合,使主原料和副原料及桑木耳混合,并逐步形成为具有独特香味的健康饮料。上述健康饮料对男女老少皆宜,除了主原料、副原料及桑木耳各自效果之外,上述原料经过发酵形成新的效果,长期饮用,有利于健康,而且可有效治疗哮喘、感冒、咳嗽、多痰等症。
Claims (2)
1.一种可有效预防和治疗哮喘的健康饮料的制造方法,其特征在于,包括以下步骤:
混合步骤,将洗净并切细的作为主原料的丝瓜、梨、金橘,萝卜、桔梗,和洗净并切细的作为副原料的雪花冬虫夏草、生姜、木瓜、石榴、银杏、葱头、茄子、枳实、仙人掌、柚子,以及红糖以60~70∶20~30∶10~35的重量比进行混合;
发酵步骤,对上述混合物在10~25℃的温度中,进行3~6个月的自然发酵;
提取步骤,对上述发酵步骤中经过发酵的混合物进行过滤,以抽取提取物;
桑木耳混合步骤,在上述提取步骤中提取的提取物1kg中混合15~25g的桑木耳粉末。
2.如权利要求1所述可有效预防和治疗哮喘的健康饮料的制造方法,其特征在于,上述桑木耳混合步骤包括:
在含20~30%酒精的溶剂92~96wt%中,浸渍4~8wt%的桑木耳,并浸渍10~16个月,使桑木耳药性浸出的步骤;
将30~40g的上述药性浸出溶液与1kg的上述提取步骤中抽取的提取液进行混合的步骤。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040108376 | 2004-12-18 | ||
KR1020040108376A KR20050012203A (ko) | 2004-12-18 | 2004-12-18 | 천식의 예방 및 치료에 효능이 있는 건강음료의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1792268A CN1792268A (zh) | 2006-06-28 |
CN100401925C true CN100401925C (zh) | 2008-07-16 |
Family
ID=36804063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101320313A Expired - Fee Related CN100401925C (zh) | 2004-12-18 | 2005-12-16 | 可有效预防和治疗哮喘的健康饮料的制造方法 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20050012203A (zh) |
CN (1) | CN100401925C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103829334A (zh) * | 2012-11-27 | 2014-06-04 | 尹善爱 | 利用印榕仙人掌的保健饮料制造方法 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100674603B1 (ko) * | 2005-05-10 | 2007-01-25 | (주)토종물산 | 도라지, 감초, 맥문동 및 모과 추출물을 함유한 호흡기질환 예방용 건강음료조성물 |
KR100769608B1 (ko) * | 2006-09-07 | 2007-10-23 | 문호일 | 배즙과 수세미외즙의 혼합 음료의 제조방법 |
KR101329452B1 (ko) * | 2006-12-15 | 2013-11-15 | 롯데칠성음료주식회사 | 석류 과즙과 배 퓨레를 이용한 석류주 및 그 제조방법 |
KR100797182B1 (ko) * | 2007-02-28 | 2008-01-23 | 최재근 | 은행 및 수세미를 포함하는 은행 수세미 조청 및 그제조방법 |
CN101627790B (zh) * | 2009-07-22 | 2012-02-01 | 刘明 | 一种银杏姜茶饮料及其制备方法 |
CN102754696B (zh) * | 2012-06-22 | 2013-08-07 | 杜双田 | 一种冬虫夏草菌株及其制备的虫草核桃肽保健饮品 |
CN103519171B (zh) * | 2013-10-17 | 2015-03-04 | 天津市星河系科技有限公司 | 一种仙人掌酵素的制备方法 |
CN104872356A (zh) * | 2015-06-17 | 2015-09-02 | 黄玲珠 | 一种治疗口腔疾病的软糖及其制作方法 |
CN106616098A (zh) * | 2016-09-27 | 2017-05-10 | 临沂大学 | 一种润肺止咳的保健饮料及其制备方法 |
KR101970320B1 (ko) * | 2017-06-23 | 2019-04-18 | 대구가톨릭대학교산학협력단 | 모과 발효액을 유효성분으로 함유하는 호흡기 질환의 예방, 개선 또는 치료용 조성물 및 이의 제조방법 |
KR101980592B1 (ko) * | 2017-11-27 | 2019-05-21 | 윤용길 | 모과를 이용한 호흡기 질환 완화용 건강 패치 제조방법 |
CN108308472B (zh) * | 2018-03-22 | 2021-05-25 | 浙江师范大学 | 洋葱山楂功能性饮料及其制备方法 |
KR102252268B1 (ko) * | 2018-10-30 | 2021-05-14 | 농업회사법인 주식회사 장수식품 | 배 및 유자를 포함하는 기관지 질환 예방 또는 개선용 식품조성물의 제조방법 및 이에 따라 제조된 식품조성물 |
KR102034238B1 (ko) * | 2019-05-16 | 2019-10-18 | 주식회사 네이처셀 | 천연재료를 이용한 기관지 건강에 도움이 되는 복합 발효효소액의 제조방법 |
KR102268219B1 (ko) * | 2019-05-29 | 2021-06-23 | 농업회사법인 주식회사 합천봉황농원 | 생강, 무, 도라지 및 솔잎을 유효성분으로 포함하는 액상차 조성물 |
KR102316867B1 (ko) | 2019-10-22 | 2021-10-26 | 곡성능이영농조합법인 | 능이버섯을 주로하는 건강음료 조성물 및 그를 이용한 건강음료의 제조방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1118231A (zh) * | 1995-08-11 | 1996-03-13 | 吴福香 | 丝瓜保健饮料 |
CN1376428A (zh) * | 2002-04-18 | 2002-10-30 | 袁智家 | 解酒保健饮料 |
CN1448081A (zh) * | 2002-12-18 | 2003-10-15 | 李永胜 | 一种预防治疗咳嗽气喘梨桃杏蜜糖块 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960008650B1 (ko) * | 1994-03-15 | 1996-06-28 | 황맹희 | 농산물을 주재로 한 발효음료의 제조방법 |
KR100341344B1 (ko) * | 1999-08-18 | 2002-06-21 | 여소현 | 수세미 추출물을 이용한 엑기스 제조방법 |
JP3502316B2 (ja) * | 2000-01-11 | 2004-03-02 | ハウス食品株式会社 | 発酵飲料の製造方法 |
KR20010114010A (ko) * | 2000-06-20 | 2001-12-29 | 이은우 | 쓴맛과 아린 맛을 제거한 도라지 쥬스 및 그 제조방법 |
KR100336649B1 (ko) * | 2000-12-26 | 2002-05-16 | 강창환 | 장 청소 및 변비 해소 기능의 야채 효소 음료 조성물 |
KR20030015964A (ko) * | 2001-08-18 | 2003-02-26 | 문상식 | 산야초 채소등을 재료로 한 발효식품의 제조방법 |
-
2004
- 2004-12-18 KR KR1020040108376A patent/KR20050012203A/ko not_active Application Discontinuation
-
2005
- 2005-12-16 CN CNB2005101320313A patent/CN100401925C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1118231A (zh) * | 1995-08-11 | 1996-03-13 | 吴福香 | 丝瓜保健饮料 |
CN1376428A (zh) * | 2002-04-18 | 2002-10-30 | 袁智家 | 解酒保健饮料 |
CN1448081A (zh) * | 2002-12-18 | 2003-10-15 | 李永胜 | 一种预防治疗咳嗽气喘梨桃杏蜜糖块 |
Non-Patent Citations (2)
Title |
---|
治疗哮喘的茶疗方. 李刚.绿化与生活,第6期. 2003 |
治疗哮喘的茶疗方. 李刚.绿化与生活,第6期. 2003 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103829334A (zh) * | 2012-11-27 | 2014-06-04 | 尹善爱 | 利用印榕仙人掌的保健饮料制造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1792268A (zh) | 2006-06-28 |
KR20050012203A (ko) | 2005-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100401925C (zh) | 可有效预防和治疗哮喘的健康饮料的制造方法 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
KR101018065B1 (ko) | 대추를 사용한 건강음료 제조방법 및 이에 의해 제조된 건강음료 | |
CN102657278A (zh) | 一种芦笋养生茶 | |
CN107586682A (zh) | 一种露酒的酿制方法 | |
CN106259071A (zh) | 一种河蟹的天然养殖方法 | |
KR101202988B1 (ko) | 건강 약차 및 그 제조방법 | |
CN104000195B (zh) | 清肺排毒口服液及其生产方法 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 | |
CN104206581A (zh) | 一种莞香花茶饮料及其制作工艺 | |
CN106857858A (zh) | 具有润肠排毒功效的富硒芒果水牛奶片及其制备方法 | |
CN106937718A (zh) | 一种双海藻花粉植物复合饮料及其制备方法 | |
CN105942115A (zh) | 芦荟冬瓜发酵饮料及其制备方法 | |
CN112586735A (zh) | 一种具活血美颜功效的三七复合酵素及其制备方法 | |
CN105192821A (zh) | 一种桑叶食品及其制作方法 | |
CN109876053A (zh) | 一种祛痘消炎、清肝解毒的组方及其制法 | |
CN108465011A (zh) | 一种抑制d-二聚体升高的组合物及其制备方法 | |
CN110100985A (zh) | 保健品饮料 | |
KR102401616B1 (ko) | 누에 아미노산을 이용한 복합 비료 및 그 제조 방법 | |
CN107518355A (zh) | 一种食品果酱及其制作方法 | |
CN108552528A (zh) | 一种保护血管及增强免疫力猕猴桃酵素及其生产方法 | |
CN106962548A (zh) | 一种保健凉茶及其制备方法 | |
CN107137451A (zh) | 羊蹄草栝楼固体饮片的制备方法 | |
CN106135540A (zh) | 一种解腻消食凉茶饮料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |